Board meeting for Sept quarter results postponed, rescheduled to November 14
Parmax Pharma has postponed its Board Meeting that was scheduled for Friday, 13th November, 2026.
By ScoutQuest · · 1 min read
- Original board meeting date
- Friday, 13th November, 2026
- Rescheduled board meeting date
- Saturday, 14th November, 2026
- Agenda
- approval of unaudited financial results for the quarter and half year ended September 30, 2026, and shifting of the Registered Office
What the company told the exchange
Parmax Pharma has informed BSE that the Board Meeting earlier scheduled for Friday, 13th November, 2026 has been postponed. The company cites "unavoidable circumstances" as the reason.
The meeting has been rescheduled to Saturday, 14th November, 2026 — a shift of one day from the original date.
What the rescheduled meeting will take up
- To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.
- Shifting of the Registered Office of the Company.
Background
This notice refers to the company's earlier intimation dated 10th November, 2026, in which the original meeting date of 13th November, 2026 was communicated.
Why investors watch this
A board meeting to approve quarterly and half-yearly results is a routine but important event. Any change in the date can matter to readers because the results themselves will now come on the revised date. The update attributes the change to "unavoidable circumstances" and does not set out anything further.
The second agenda item, shifting of the Registered Office, is a separate corporate matter being placed before the Board at the same meeting.
What to note
- The postponement is short — the meeting is now a day later.
- Both agenda items, the results and the registered office shift, move to the new date together.
- The intimation is signed by Umang Gosalia, Managing Director.
Also from Parmax Pharma
Standalone results for the quarter Ended 30.09.2026
16 Nov 2026
Internal auditor appointed; board also clears state shift and Rs.50 crore limits
14 Nov 2026
Board approves registered office shift to Maharashtra, Rs.50 crore charge and borrowing limits
14 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.